ANAPA BIOTECH A/S: Financial statements 2024
CVR: 27585167
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 7,492,906 and a net result of DKK 7,646,635 compared with DKK 1,674,278 the year before. That is an increase of 342.4% compared with the year before. Equity in the 2024 report amounted to DKK 10,481,191. The solvency ratio was 99.5%.
- Gross Profit
- DKK 7,492,906
- Profit/Loss
- DKK 7,646,635
- Equity
- DKK 10,481,191
- Total Assets
- DKK 10,537,202
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 7.5M | 7.6M | 10.5M | - |
| 2023 | - | 1.7M | 1.7M | 2.8M | - |
| 2022 | - | 249K | 76K | 1.2M | - |
| 2021 | - | 1M | 612K | 1.1M | - |
| 2020 | - | 526K | 472K | 472K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ANAPA BIOTECH A/S has published its annual report for 2023. Gross profit came to DKK 1,693,656, and the net result was DKK 1,674,278.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.
